NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Thermo Fisher Scientific Prices Offering of Yen-Denominated Senior Notes

by Ed Johnson
October 15, 2022
A A

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) the world leader in serving science, announced today that it has priced an offering of ¥109.5 billion aggregate principal amount (the “Offering”) of the following yen-denominated notes, each issued at par:

  • ¥22,300,000,000 aggregate principal amount of its 0.853% Senior Notes due 2025 (the “2025 Notes”),
  • ¥28,900,000,000 aggregate principal amount of its 1.054% Senior Notes due 2027 (the “2027 Notes”),
  • ¥4,700,000,000 aggregate principal amount of its 1.279% Senior Notes due 2029 (the “2029 Notes”),
  • ¥6,300,000,000 aggregate principal amount of its 1.490% Senior Notes due 2032 (the “2032 Notes”),
  • ¥14,600,000,000 aggregate principal amount of its 2.069% Senior Notes due 2042 (the “2042 Notes”), and
  • ¥33,300,000,000 aggregate principal amount of its 2.382% Senior Notes due 2052 (the “2052 Notes” and, collectively with the 2025 Notes, the 2027 Notes, the 2029 Notes, the 2032 Notes and the 2042 Notes, the “Notes”).

The Offering is expected to close on or about October 20, 2022, subject to customary closing conditions. The Notes will pay interest on a semi-annual basis.

Thermo Fisher intends to use the net proceeds of the Offering for general corporate purposes, which may include the acquisition of companies or businesses, repayment and refinancing of debt, working capital and capital expenditures or the repurchase of its outstanding equity securities or it may temporarily invest the net proceeds in short-term, liquid investments until they are used for their ultimate purpose.

The joint book-running managers for the Offering are Citigroup Global Markets Limited, Mizuho Securities USA LLC, MUFG Securities EMEA plc and SMBC Nikko Securities America, Inc.

The Offering is being made pursuant to an effective registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission (the “SEC”). Prospective investors should read the prospectus forming a part of that registration statement and the prospectus supplement related to the Offering and the other documents that Thermo Fisher has filed with the SEC for more complete information about Thermo Fisher and the Offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Thermo Fisher, the underwriters or any dealer participating in the Offering will arrange to send you the prospectus if you request it by calling Citigroup Global Markets Limited at 1-800-831-9146, Mizuho Securities USA LLC at 1-866-271-7403, MUFG Securities EMEA plc at +44-20-7577-2206 or SMBC Nikko Securities America, Inc. at 1-888-868-6856.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about Thermo Fisher’s intended use of proceeds. These statements involve a number of risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including risks and uncertainties relating to capital markets conditions and completion of the Offering. Additional important factors and information regarding Thermo Fisher’s business that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the prospectus dated February 25, 2022 and the prospectus supplement dated October 11, 2022 related to the Offering, which is on file with the SEC and available in the “Investors” section of our website under the heading “SEC Filings,” and the documents incorporated by reference into the prospectus and prospectus supplement. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if circumstances change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

Tags: < Financial Results
ShareTweetShareSend

Related Industries

Healthcare

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

March 16, 2023
Healthcare

Medtronic named one of World’s Most Ethical Companies

March 14, 2023
Healthcare

Pfizer Invests $43 Billion to Battle Cancer

March 14, 2023
Healthcare

AskBio Announces Gustavo Pesquin as New CEO

March 10, 2023
Healthcare

Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.

March 9, 2023
Healthcare

Interview with Dr. Erik Walker, Board Chairman, Orlando Health Network

March 6, 2023

Accelerate Learning Announces Majority Investment from Providence Equity Partners

February 22, 2023

...

Infineon to acquire GaN Systems, strengthening its GaN portfolio and further reinforcing its global leadership in Power Systems

March 3, 2023

...

Amway Reports Sales of $8.1B for 2022

February 28, 2023

...

Honeywell Joins The Marriott Design Lab To Collaborate On An Improved In-Room Guest Experience

March 10, 2023

...

AstraZeneca Completes Acquisition of CinCor

February 25, 2023

...

Kimberly-Clark Ranks Third Among Barron’s 100 Most Sustainable Companies Of 2023

March 17, 2023

...

Interview with Bill Frain, CEO, Liberty Defense

March 20, 2023

...

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

March 16, 2023

...

Interview with Dr. Erik Walker, Board Chairman, Orlando Health Network

March 6, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

INDUSTRIES

  • Aero
  • Agriculture
  • ALL
  • Automotive
  • Business Service
  • Chemical
  • Construction
  • Construction Materials
  • Consumer
  • Education
  • Energy
  • Entertainment
  • Environmental
  • F&B
  • Financial
  • Healthcare
  • Hospitality
  • Industrial
  • IT
  • IT Hardware
  • Logistic
  • Metal & Mining
  • Packaging & Paper
  • Rail
  • Real Estate
  • Telecom

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.